A multinational, randomized, double-blind, placebo-controlled Phase 2 study to assess safety and efficacy of olesoxime in Type 2 or non-ambulatory Type 3 spinal muscular atrophy

2017 ◽  
Vol 27 ◽  
pp. S29
Author(s):  
J. Buchbjerg ◽  
E. Bertini ◽  
E. Dessaud ◽  
E. Mercuri ◽  
F. Muntoni ◽  
...  
Keyword(s):  
Spinal Muscular Atrophy ◽  
Muscular Atrophy ◽  
Phase 2 ◽  
Double Blind ◽  
Safety And Efficacy ◽  
Double Blind Placebo ◽  
Phase 2 Study ◽  
Type 3

T136. Safety and Efficacy of Intravenous Ganaxolone in Severe Postpartum Depression: Results From a Double-Blind, Placebo-Controlled Phase 2 Study

2019 ◽  
Vol 85 (10) ◽  
pp. S181-S182
Author(s):  
Rolando Gutierrez-Esteinou ◽  
Bassem Maximos ◽  
Robert Riesenberg ◽  
Kimball A. Johnson ◽  
Alex Aimetti ◽  
...  
Keyword(s):  
Postpartum Depression ◽  
Phase 2 ◽  
Double Blind ◽  
Safety And Efficacy ◽  
Double Blind Placebo ◽  
Phase 2 Study

A 12‐week, randomized, double‐blind, placebo‐controlled, four‐arm dose‐finding phase 2 study evaluating bexagliflozin as monotherapy for adults with type 2 diabetes

2019 ◽  
Vol 22 (4) ◽  
pp. 566-573 ◽  
Author(s):  
Yuan‐Di Halvorsen ◽  
Geoffrey Walford ◽  
Tara Thurber ◽  
Heidy Russell ◽  
Monica Massaro ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Dose Finding ◽  
Phase 2 ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Phase 2 Study
Sign in / Sign up

Export Citation Format

Share Document